Latest Dana-Farber Cancer Institute Stories
A leukemia drug may be used as a new target therapy for some lung cancer patients.
COLUMBUS, Ga., April 4, 2011 /PRNewswire/ -- Aflac, the company that helps employers enhance benefits offerings to employees, today announced it will donate a total of $1,060,000 to the American Association for Cancer Research (AACR) to help defray the costs facing cancer researchers.
Scientists have achieved one of the oldest and most rarely achieved goals of cancer researchâ€”they have found a way to â€œdistractâ€ cancer cells from their normal activities and make them act like normal cells.
A section of the AIDS virus's protein envelope once considered an improbable target for a vaccine now appears to be one of the most promising.
Innovative international research consortium's first study opens SAN FRANCISCO, March 28, 2011 /PRNewswire-USNewswire/ -- The Addario Lung Cancer Medical Institute (ALCMI, voiced as "Alchemy") today announced the enrollment of the initial subjects into its inaugural clinical trial known as CASTLE, targeting 250 subjects over two years among academic and community medical centers in the United States.
The U.S. Food and Drug Administration today approved the use of ipilimumab for the treatment of previously treated metastatic melanoma.
BOSTON, March 24, 2011 /PRNewswire/ -- John Legere, CEO of Global Crossing, is nearing the finish line of his goal to raise $1 million for cancer research at Dana-Farber Cancer Institute.
Scientists reported on Wednesday that they have sequenced the entire genetic code of 38 multiple myeloma patients, and have uncovered the most likely genetic causes of the aggressive blood cancer.
Dana-Farber Cancer Institute scientists report they have shrunk or slowed the growth of notoriously resistant pancreatic tumors in mice, using a drug routinely prescribed for malaria and rheumatoid arthritis.
Using whole genome sequencing and multiple tumor samples, researchers uncover genes tied to prostate cancer growth.
- A serpent whose bite was fabled to produce intense thirst.